The global ibuprofen market was valued at US$ --in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the incidence of inflammatory and pain mediated diseases, headaches and rate of incidence of diseases like cancer,

Global ibuprofen market segmented on the basis of indication, route of administration, distribution channel and Geography.

For request sample: [URL]https://www.precisionbusinessinsights.com/request-sample?product_id=35367[/URL]

Oral Ibuprofen Formulation Dominates the Global Ibuprofen market

Based on route of administration, global ibuprofen market segmented into oral route and parenteral route. The formulation which can be given through oral route like tablets and capsules dominated the global ibuprofen market in 2018 and estimated to dominate over the forecast period, owing to the ease of administration, low cost, more availability, less manufacturing cost and more profits for the manufacturing companies.

PBI’s global ibuprofen market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to advance healthcare system, enhanced R&D activities, increasing demand due to less adverse effects and more therapeutic effect, and the presence of major market players in the region and rise in healthcare expenditure are propel the market.

Launch of newer formulation products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

Global ibuprofen market further reveals that the key players increasingly adopting strategies such as launch of newer technologies of needle free injector products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

Key player’s profiles in the report are

• Xinhua Pharmaceutical (China)

• IOLCP (India)

• Granules Biocause (India)

• Shasun (India)

• BASF (US)

• SI Group (US)

• Xinhua-Perrigo Pharmaceutical (China)

• Hisoar (U.S.)

• Alveda Pharmaceuticals, Inc (Canada)

• Grifols S.A. (Spain)

• Al Nabeel International Ltd.,( Sultanate of Muscat and Oman)

Detailed Segmentation

By Indication

• Fever

• Pain

• Inflammation

By Route of administration

• Oral

• Parenteral

By Distribution channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

• Others

Geography

• North America

? U.S

• Canada

• Europe

• Germany

• France

• U.K

• Italy

• Spain

• Russia

• Poland

• Rest of Europe

• Asia-Pacific

• Japan

• China

• India

• Australia & New Zealand

• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

• South Korea

• Rest of Asia-Pacific

• Latin America

• Brazil

• Mexico

• Argentina

• Venezuela

• Rest of Latin America

• Middle East and Africa (MEA)

• Gulf Cooperation Council (GCC) Countries

• Israel

• South Africa

• Rest of MEA

For more information: [URL]https://www.precisionbusinessinsights.com/market-reports/global-ibuprofen-market[/URL]